ECT in Parkinson's disease, with and without depression

Author： Trimble M.R.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 245-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of depression in Parkinson's disease: a meta-analysis

By Verhey F.R.J.   Havermans A.G.M.   Klaassen T.   van Praag H.M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 246-246

Elsevier

Access to resources Recommend Favorite

Depression in Parkinson's Disease: Pharmacological Characteristics and Treatment

By Tom T.  

Drugs & Aging, Vol. 12, Iss. 1, 1998-01 ,pp. : 55-74

Adis International

Access to resources Recommend Favorite

Use of antidepressants for depression in patients with Parkinson's disease

By Pae Chi-Un  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 3, 2013-02 ,pp. : 255-257

Informa Healthcare

Access to resources Recommend Favorite

AMPA Receptor Potentiators: Application for Depression and Parkinson's Disease

By  

Current Drug Targets, Vol. 8, Iss. 5, 2007-05 ,pp. : 603-620

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Dopamine Agonists in the Treatment of Depression in Patients with Parkinson's Disease: A Systematic Review

By Leentjens Albert F.G.  

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 273-286

Adis International

Access to resources Recommend Favorite